TrialCancer communications (London, England)2018

Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study.

Xin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.